Purpose: To evaluate the in vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae isolated from outbreaks of infectious keratitis in Brazil.
L aser in situ keratomileusis (LASIK), a surgical procedure for the correction of myopia, astigmatism, and hyperopia, has been reported to have a low incidence of sight-threatening complications, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] although the exact incidence and etiology of infectious keratitis related to LASIK in our country (Brazil) is unknown. Worldwide, microorganisms isolated from infected corneas following LASIK for the correction of refractive errors are Staphylococcus aureus, 16 Staphylococcus epidermidis, 17 Nocardia asteroides, 18, 19 Streptococcus pneumoniae, 17 Streptococcus viridans, 17 Aspergillus fumigatus, 20 and Herpes simplex 21 ; in fact, even polymicrobial keratitis 17, [22] [23] [24] and bilateral infection 25, 26 have also been documented. 17 Most mycobacterial corneal infections are caused by M. chelonae, M. abscessus, or M. fortuitum, species also known as nontuberculous mycobacteria (NTM) or atypical mycobacteria species. 17, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] In Brazil, only M. abscessus and M. chelonae have been reported, although M. fortuitum has been isolated from plastic surgery wounds (Sampaio et al, unpublished data).
In general, LASIK-related infectious keratitis is difficult to manage because of the intrastromal localization of the lesion, its slow response to therapy, inadequate drug penetration, and bacterial resistance to most conventional antibiotics. 17 Although fortified antibiotics are often prescribed for infectious keratitis treatment with good therapeutic results, there are some limitations their its use, such as toxicity, limited availability of infectious site, a short shelf life, and a need for refrigeration. Fluoroquinolones were subsequently introduced as alternatives to fortified antibiotics [42] [43] [44] and have become the treatment of choice for various corneal infections.
Ciprofloxacin and ofloxacin, 2 widely used fluoroquinolones, have been demonstrated to be particularly effective in treating bacterial keratitis and conjunctivitis. 49, 50 This class of antibiotic provides broad-spectrum coverage against aerobic gram-negative and gram-positive bacteria, low toxicity, good ocular surface penetration, prolonged tear film concentration, and stability at room temperature; furthermore, these are readily available. 43, 45, 46 In the last decade, the fluoroquinolones have become 1 of the dominant classes of antimicrobial agents for ophthalmic prescription as a topical medication, with broad-spectrum coverage against most aerobic gram-negative and grampositive bacteria, against some anaerobic species, and against Mycobacteria species.
Although in vitro activity does not always accurately predict therapeutic efficacy, in vitro tests may aid in determining the best antibiotic coverage, particularly when MIC results are available. 53 Some in vitro studies have shown that amikacin, ciprofloxacin, norfloxacin, vancomycin, tobramycin, and gentamicin can be active against rapidly growing mycobacteria (RGM), [32] [33] [34] [54] [55] [56] but there are few drugs that are active against M. chelonae and M. abscessus. 28, 52, [57] [58] [59] In vitro susceptibility tests with the newer fluoroquinolones (8-methoxy fluoroquinolones), gatifloxacin and moxifloxacin, have shown that gatifloxacin is more active than ciprofloxacin against various mycobacterial species. 28, 30, [60] [61] [62] [63] [64] The purpose of the study described herein was to assess the in vitro susceptibility of M. chelonae and M. abscessus isolates recovered from keratitis following refractive surgery (LASIK).
MATERIALS AND METHODS
Tests to determine the in vitro activities of fluoroquinolones against M. chelonae and M. abscesssus, from clusters of infectious keratitis outbreaks following LASIK for myopia correction recovered between 1998 and 1999 and also between 2000 and 2003, were conducted at Universidade Federal de São Paulo, Brazil. Only 1 isolate per patient was included in the study. Not all the isolates from each outbreak were tested, except for outbreaks R1 and R2, which comprised 2 and 16 isolates, respectively, but only 1 isolate from R1 and 2 from R2 were available for susceptibility testing. Isolate number 12 is not related to any of the other clusters. Clonality analysis was performed using a randomly amplified polymorphic DNA (RAPD) technique as described elsewhere. This analysis showed that M. chelonae clusters and M. abscessus clusters were not related.
Corneal scrapings were cultured on solid (sheep blood, chocolate, Sabouraud, and nonnutrient agar) and liquid media (brain-heart infusion and thioglycolate broth). In all cases, smears were also obtained and stained with Gram, Giemsa, and Ziehl-Neelsen methods.
Mycobacterial isolates were identified by conventional methods (growth rate, pigment production, acid-fast staining) and molecular techniques as described by Telenti et al 65 and Roth et al. 66 MICs were determined as previously described by Woods et al. 72 In brief, all isolates were subcultured on a sheep blood agar, incubated in ambient air at 30°C for 72 to 96 hours, and then checked for purity. Bacterial suspensions equivalent to the 1.0 McFarland turbidity standard were prepared in Mueller-Hinton broth. Bacterial suspensions were inoculated on 150-mm-diameter Mueller-Hinton blood agar plates, and E-test strips were applied as soon as no visible condensation was observed on the agar surface. Plates were incubated at 30°C in ambient air for 72 hours. The MIC was recorded as the point of intersection between the zone edge and the strip. Staphylococcus aureus ATCCÒ 29213 was used as a quality control as described by the National Committee for Clinical Laboratory Standards (NCCLS). 67 Ciprofloxacin but not gatifloxacin, ofloxacin, or moxifloxacin breakpoints for RGM have been addressed in the NCCLS document M24-A. 68 Interpretative criteria used for interpretation of gatifloxacin and ofloxacin MIC values were those published by the NCCLS for Enterobacteriaceae and Staphylococcus spp as proposed by Brown-Elliott et al. 30 Isolates with MICs # 1, equal to 2 or 4, and $ 8 mg/mL were, respectively, interpreted as susceptible, intermediate, and resistant to ciprofloxacin, gatifloxacin, or ofloxacin. Interpretative criteria used for interpretation of moxifloxacin MICs were those published by the NCCLS for 
RESULTS
Fifteen M. chelonae and 3 M. abscessus isolates were tested against ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin. These strains were isolated from 3 different outbreaks that occurred in Table 1) .
For 1 strain of M. chelonae from the SP-2 outbreak, the MIC levels for ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin were 0.38 mg/mL, 0.125 mg/mL, 0.032 mg/mL, and 0.032 mg/mL, respectively. MIC 90 levels for the other 14 strains of M. chelonae and for the 3 M. abscessus isolates were equal to or greater than 32 mg/mL for all fluoroquinolones tested.
DISCUSSION
RGM are acid-fast aerobic bacilli responsible for keratitis infection following corneal trauma, LASIK, photorefractive keratectomy, 29, [31] [32] [33] [34] [35] [36] [37] [38] and radial keratotomy. Because Ziehl-Neilsen staining is not routinely performed on corneal scrapings, diagnosis of mycobacterial keratitis and implementation of adequate therapy may be postponed if there is no clinical suspicion and thus no specific order for this rapid test. Smears stained by the Gram method are not adequate to detect mycobacteria because they appear faintly stained and can be misdiagnosed as Nocardia spp or Corynebacterium spp. 39, 69 Another peculiarity of Mycobacterium spp is the development of resistance to organomercurials, chlorine, 2% concentrations of formaldehyde and alkaline glutaraldehyde, and other commonly used disinfectants, resulting in difficult disinfections of certain surgical instruments. Iodine-povidone does appear to have some bactericidal activity against these microorganisms.
70
In general, mycobacteria have a slower growth rate 71 than other pathogens, but RGM colonies are easily visible after 3 to 7 days 72 ; indeed, some of our isolates produced pinpoint colonies after 2 days. Although the most commonly used culture media for the recovery of mycobacteria are the Middlebrook 7H9 and Dubos tween albumin broths and LowensteinJensen medium, we were able to isolate M. abscessus and M. chelonae on media used routinely for primary culture of infectious corneal ulcers (sheep blood agar, chocolate agar, and Sabouraud agar). 73 Keratitis caused by RGM is characterized by its indolent progression and poor response to antibiotics, and its management is usually very difficult. Delayed diagnosis, use of corticosteroids, and poor penetration of topical medication may contribute to the ineffectiveness of medical therapy. Most isolates described in the literature are susceptible to amikacin or tobramycin, one of the fluoroquinolones, and to clarithromycin. 30, 33, 56, 71, 74 A combination of these drugs as the initial topical treatment of suspected cases until culture and susceptibility tests are available may be warranted.
Determination of MIC levels for various antibiotics is important to select the appropriate drug treatment. Unfortunately, in the present study MIC levels of the fluoroquinolones for M. chelonae and M. abscessus do not support their use, and additional studies with the inclusion of more isolates are necessary.
Among 9 isolates from outbreak SP-2, all belonging to a single strain, 1 was susceptible to all fluoroquinolones tested, and all others were resistant. All patients received topical medication containing different antimicrobials in different concentrations immediately after surgery and before diagnosis of mycobacterial infection. The differences in susceptibilities in isolates from the same cluster, as observed here, suggest that previous management of the patients, especially the use of antimicrobials, and other unknown factors deserving further investigation can influence the results of susceptibility tests.
Our MIC 90 data for M. chelonae and M. abscessus tested against fourth-generation fluoroquinolones are different from those reported by other researchers in different geographic areas of the United States. 30 This finding is a clear indication of microbial diversity and the need to perform susceptibility testing on these isolates. Therapy for patients infected with RGM is of the utmost concern, as is preoperative and postoperative prophylaxis, and we believe that the fourthgeneration fluoroquinolones, moxifloxacin and gatifloxacin, should be tested further, and that correlation with clinical effectiveness should be undertaken.
Laboratory data are the basis for empirical therapy because bacterial susceptibility patterns can differ depending on the geographic location, so the place where the study was conducted must be considered in evaluating reports of laboratory and clinical results of treatment of infectious diseases of the eye.
The MIC levels for second-or fourth-generation fluoroquinolones against RGM isolated in Brazil from infectious keratitis showed that most of isolates are resistant to these drugs. Further studies will be necessary to compare in vivo efficacy because in vitro tests did not give support to advocate the treatment of RGM keratitis with fluoroquinolones in our geographic area.
